| 综述 |
|
|
|
|
| CD133(Prominin-1)的结构、功能及其相关抗体的研究进展 * |
程雨涵,龚熹,罗玉萍( ) |
| 南昌大学生命科学学院 南昌 330031 |
|
| Advances in Studies on the Structure, Function and Related Antibodies of CD133 (Prominin-1) |
| Yu-han CHENG,Xi GONG,Yu-ping LUO() |
| School of Life Sciences, Nanchang University, Nanchang 330031, China |
| [1] |
Miraglia S, Godfrey W, Yin A H , et al. A novel five-transmembrane hematopoietic stem cell antigen: isolation, characterization, and molecular cloning. Blood, 1997,90(12):5013-5021.
|
| [2] |
Wuchter C, Ratei R, Spahn G , et al. Impact of CD133 (AC133) and CD90 expression analysis for acute leukemia immunophenotyping. Haematologica, 2001,86(2):154-161.
|
| [3] |
Mizrak D, Brittan M, Alison M . CD133: molecule of the moment. J Pathol, 2008,214(1):3-9.
doi: 10.1002/(ISSN)1096-9896
|
| [4] |
Irollo E, Pirozzi G . CD133: to be or not to be, is this the real question. Am J Transl Res, 2013,5(6):563-581.
|
| [5] |
Zhou Q, Chen A, Song H , et al. Prognostic value of cancer stem cell marker CD133 in ovarian cancer: a meta-analysis. Int J Clin Exp Med, 2015,8(3):3080-3088.
|
| [6] |
Yang Z, Chen Y, Lillo C , et al. Mutant prominin 1 found in patients with macular degeneration disrupts photoreceptor disk morphogenesis in mice. J Clin Invest, 2008,118(8):2908-2916.
|
| [7] |
Imani S, Cheng J, Shasaltaneh M D , et al. Genetic identification and molecular modeling characterization reveal a novel PROM1 mutation in Stargardt4-like macular dystrophy. Oncotarget, 2018,9(1):122-141.
|
| [8] |
Pras E, Abu A, Rotenstreich Y , et al. Cone-rod dystrophy and a frameshift mutation in the PROM1 gene. Mol Vis, 2009,15:1709-1716.
|
| [9] |
Permanyer J, Navarro R, Friedman J , et al. Autosomal recessive retinitis pigmentosa with early macular affectation caused by premature truncation in PROM1. Invest Ophthalmol Vis Sci, 2010,51(5):2656-2663.
doi: 10.1167/iovs.09-4857
|
| [10] |
Jaszai J, Fargeas C A, Florek M , et al. Focus on molecules: prominin-1 (CD133). Exp Eye Res, 2007,85(5):585-586.
doi: 10.1016/j.exer.2006.03.022
|
| [11] |
Fargeas C A, Florek M, Huttner W B , et al. Characterization of prominin-2, a new member of the prominin family of pentaspan membrane glycoproteins. J Biol Chem, 2003,278(10):8586-8596.
doi: 10.1074/jbc.M210640200
|
| [12] |
Corbeil D, Roper K, Fargeas C A , et al. Prominin: a story of cholesterol, plasma membrane protrusions and human pathology. Traffic, 2001,2(2):82-91.
doi: 10.1034/j.1600-0854.2001.020202.x
|
| [13] |
Donovan L K, Pilkington G J . CD133: holy of grail of neuro-oncology or promiscuous red-herring. Cell Prolif, 2012,45(6):527-537.
doi: 10.1111/cpr.2012.45.issue-6
|
| [14] |
Bidlingmaier S, Zhu X, Liu B . The utility and limitations of glycosylated human CD133 epitopes in defining cancer stem cells. J Mol Med (Berl), 2008,86(9):1025-1032.
doi: 10.1007/s00109-008-0357-8
|
| [15] |
Fargeas C A, Fonseca A V, Huttner W B , et al. Prominin-1 (CD133): from progenitor cells to human diseases. Future Lipidology, 2006,1(2):213-225.
doi: 10.2217/17460875.1.2.213
|
| [16] |
Shmelkov S V, St Clair R, Lyden D , et al. AC133/CD133/Prominin-1. Int J Biochem Cell Biol, 2005,37(4):715-719.
doi: 10.1016/j.biocel.2004.08.010
|
| [17] |
Bauer N, Fonseca A V, Florek M , et al. New insights into the cell biology of hematopoietic progenitors by studying prominin-1 (CD133). Cells Tissues Organs, 2008,188(1-2):127-138.
doi: 10.1159/000112847
|
| [18] |
Florek M, Bauer N, Janich P , et al. Prominin-2 is a cholesterol-binding protein associated with apical and basolateral plasmalemmal protrusions in polarized epithelial cells and released into urine. Cell Tissue Res, 2007,328(1):31-47.
doi: 10.1007/s00441-006-0324-z
|
| [19] |
Florek M, Haase M, Marzesco A M , et al. Prominin-1/CD133, a neural and hematopoietic stem cell marker, is expressed in adult human differentiated cells and certain types of kidney cancer. Cell Tissue Res, 2005,319(1):15-26.
doi: 10.1007/s00441-004-1018-z
|
| [20] |
Walker T L, Wierick A, Sykes A M , et al. Prominin-1 allows prospective isolation of neural stem cells from the adult murine hippocampus. J Neurosci, 2013,33(7):3010-3024.
doi: 10.1523/JNEUROSCI.3363-12.2013
|
| [21] |
Maw M A, Corbeil D, Koch J , et al. A frameshift mutation in prominin (mouse)-like 1 causes human retinal degeneration. Hum Mol Genet, 2000,9(1):27-34.
doi: 10.1093/hmg/9.1.27
|
| [22] |
邵志华, 李瑛泽, 许洁 , 等. Prominin1在C57BL/6小鼠视网膜色素上皮中的表达. 同济大学学报(医学版), 2018,39(1):23-28.
|
|
Shao Z H, Li Y Z, Xu J , et al. Expression of Prominin1 in retinal pigment epithelium of C57BL/6 mice at different development stages. Journal of Tongji University(Medical Science), 2018,39(1):23-28.
|
| [23] |
Zacchigna S, Oh H, Wilsch-Brauninger M , et al. Loss of the cholesterol-binding protein prominin-1/CD133 causes disk dysmorphogenesis and photoreceptor degeneration. J Neurosci, 2009,29(7):2297-2308.
doi: 10.1021/jp035547p
pmid: 19228982
|
| [24] |
Jaszai J, Fargeas C A, Graupner S , et al. Distinct and conserved prominin-1/CD133-positive retinal cell populations identified across species. PLoS One, 2011,6(3):e17590.
doi: 10.1371/journal.pone.0017590
pmid: 21407811
|
| [25] |
Yin A H, Miraglia S, Zanjani E D , et al. AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood, 1997,90(12):5002-5012.
|
| [26] |
Zhu L, Gibson P, Currle D S , et al. Prominin 1 marks intestinal stem cells that are susceptible to neoplastic transformation. Nature, 2009,457(7229):603-607.
|
| [27] |
Shankland S J, Pippin J W, Duffield J S . Progenitor cells and podocyte regeneration. Semin Nephrol, 2014,34(4):418-428.
doi: 10.1016/j.semnephrol.2014.06.008
|
| [28] |
Cherciu I, Barbalan A, Pirici D , et al. Stem cells, colorectal cancer and cancer stem cell markers correlations. Curr Health Sci J, 2014,40(3):153-161.
|
| [29] |
Wang J, Li F, Zhang G , et al. Two novel monoclonal antibodies against human CD133-2: distinct epitopes and agonist activity to enhance growth of CD133 expression cells in vitro. Hybridoma (Larchmt), 2010,29(3):241-249.
doi: 10.1089/hyb.2009.0113
|
| [30] |
Xu W W, Li B, Zhao J F , et al. IGF2 induces CD133 expression in esophageal cancer cells to promote cancer stemness. Cancer Lett, 2018,425:88-100.
doi: 10.1016/j.canlet.2018.03.039
|
| [31] |
Sato-Dahlman M, Miura Y, Huang J L , et al. CD133-targeted oncolytic adenovirus demonstrates anti-tumor effect in colorectal cancer. Oncotarget, 2017,8(44):76044-76056.
|
| [32] |
Adini A, Adini I, Ghosh K , et al. The stem cell marker prominin-1/CD133 interacts with vascular endothelial growth factor and potentiates its action. Angiogenesis, 2013,16(2):405-416.
doi: 10.1007/s10456-012-9323-8
|
| [33] |
Kaushal G S, Rognoni E, Lichtenberger B M , et al. Fate of prominin-1 expressing dermal papilla cells during homeostasis, wound healing and Wnt activation. J Invest Dermatol, 2015,135(12):2926-2934.
doi: 10.1038/jid.2015.319
|
| [34] |
Brossa A, Papadimitriou E, Collino F , et al. Role of CD133 molecule in Wnt response and renal repair, 2018,7(3):283-294.
|
| [35] |
Roy L, Bobbs A, Sattler R , et al. CD133 promotes adhesion to the ovarian cancer metastatic niche. Cancer Growth Metastasis, 2018,11:1-11.
|
| [36] |
Yuan F, Liu L, Lei Y , et al. MiRNA-142-3p increases radiosensitivity in human umbilical cord blood mononuclear cells by inhibiting the expression of CD133. Sci Rep, 2018,8(1):5674.
doi: 10.1038/s41598-018-23968-1
|
| [37] |
Wei Y, Jiang Y, Zou F , et al. Activation of PI3K/Akt pathway by CD133-p85 interaction promotes tumorigenic capacity of glioma stem cells. Proc Natl Acad Sci USA, 2013,110(17):6829-6834.
doi: 10.1073/pnas.1217002110
pmid: 23569237
|
| [38] |
Shimozato O, Waraya M, Nakashima K , et al. Receptor-type protein tyrosine phosphatase kappa directly dephosphorylates CD133 and regulates downstream AKT activation. Oncogene, 2015,34(15):1949-1960.
|
| [39] |
Liu C, Li Y, Xing Y , et al. The interaction between cancer stem cell marker CD133 and Src protein promotes focal adhesion kinase (FAK) phosphorylation and cell migration. J Biol Chem, 2016,291(30):15540-15550.
doi: 10.1074/jbc.M115.712976
|
| [40] |
Zhang Q, Zulfiqar F, Xiao X , et al. Severe retinitis pigmentosa mapped to 4p15 and associated with a novel mutation in the PROM1 gene. Hum Genet, 2007,122(3-4):293-299.
doi: 10.1007/s00439-007-0395-2
|
| [41] |
Bhattacharya S, Yin J, Winborn C S , et al. Prominin-1 Is a novel regulator of autophagy in the human retinal pigment epithelium. Invest Ophthalmol Vis Sci, 2017,58(4):2366-2387.
doi: 10.1167/iovs.16-21162
|
| [42] |
Kim J M, Lee C, Lee G I , et al. Identification of the PROM1 mutation p.R373C in a Korean patient with autosomal dominant Stargardt-like Macular Dystrophy. Ann Lab Med, 2017,37(6):536-539.
doi: 10.3343/alm.2017.37.6.536
|
| [43] |
Randhawa S, Sharma M . A new macular dystrophy secondary to a nove mutation in the Prominin 1(PROM1) gene. Retin Cases Brief Rep, 2017,11(Suppl 1):S62-s64.
doi: 10.1097/ICB.0000000000000405
|
| [44] |
Eidinger O, Leibu R, Newman H , et al. An intronic deletion in the PROM1 gene leads to autosomal recessive cone-rod dystrophy. Mol Vis, 2015,21:1295-1306.
|
| [45] |
Karim B O, Rhee K J, Liu G , et al. Prom1 function in development, intestinal inflammation, and intestinal tumorigenesis. Front Oncol, 2014,4:323.
|
| [46] |
Karbanova J, Laco J, Marzesco A M , et al. Human prominin-1 (CD133) is detected in both neoplastic and non-neoplastic salivary gland diseases and released into saliva in a ubiquitinated form. PLoS One, 2014,9(6):e98927.
doi: 10.1371/journal.pone.0098927
|
| [47] |
Liu Y, Ren S, Xie L , et al. Mutation of N-linked glycosylation at Asn548 in CD133 decreases its ability to promote hepatoma cell growth. Oncotarget, 2015,6(24):20650-20660.
|
| [48] |
Wang D, Guo Y, Li Y , et al. Detection of CD133 expression in U87 glioblastoma cells using a novel anti-CD133 monoclonal antibody. Oncol Lett, 2015,9(6):2603-2608.
doi: 10.3892/ol.2015.3079
|
| [49] |
Kemper K, Sprick M R, de Bree M , et al. The AC133 epitope, but not the CD133 protein, is lost upon cancer stem cell differentiation. Cancer Res, 2010,70(2):719-729.
doi: 10.1158/0008-5472.CAN-09-1820
|
| [50] |
Glumac P M, Forster C L, Zhou H , et al. The identification of a novel antibody for CD133 using human antibody phage display. The Prostate, 2018,78(13):981-991.
doi: 10.1002/pros.v78.13
|
| [51] |
Green C L, Loken M, Buck D , et al. Discordant expression of AC133 and AC141 in patients with myelodysplastic syndrome (MDS) and acute myelogeneous leukemia (AML). Leukemia, 2000,14(4):770-772.
|
| [52] |
Weigmann A, Corbeil D, Hellwig A , et al. Prominin, a novel microvilli-specific polytopic membrane protein of the apical surface of epithelial cells, is targeted to plasmalemmal protrusions of non-epithelial cells. Proc Natl Acad Sci USA, 1997,94(23):12425-12430.
doi: 10.1073/pnas.94.23.12425
|
| [53] |
Platet N, Liu S Y, Atifi M E , et al. Influence of oxygen tension on CD133 phenotype in human glioma cell cultures. Cancer Lett, 2007,258(2):286-290.
doi: 10.1016/j.canlet.2007.09.012
|
| [54] |
Christensen K, Aaberg-Jessen C, Andersen C , et al. Immunohistochemical expression of stem cell, endothelial cell, and chemosensitivity markers in primary glioma spheroids cultured in serum-containing and serum-free medium. Neurosurgery, 2010,66(5):933-947.
doi: 10.1227/01.NEU.0000368393.45935.46
|
| [55] |
Lang J, Lan X, Liu Y , et al. Targeting cancer stem cells with an 131I-labeled anti-AC133 monoclonal antibody in human colorectal cancer xenografts. Nucl Med Biol, 2015,42(5):505-512.
doi: 10.1016/j.nucmedbio.2015.01.003
|
| [56] |
Swaminathan S K, Olin M R, Forster C L , et al. Identification of a novel monoclonal antibody recognizing CD133. J Immunol Methods, 2010,361(1-2):110-115.
doi: 10.1016/j.jim.2010.07.007
|
| [57] |
Holmberg Olausson K, Maire C L, Haidar S , et al. Prominin-1 (CD133) defines both stem and non-stem cell populations in CNS development and gliomas. PLoS One, 2014,9(9):e106694.
doi: 10.1371/journal.pone.0106694
|
| [58] |
Angelotti M L, Lazzeri E, Lasagni L , et al. Only anti-CD133 antibodies recognizing the CD133/1 or the CD133/2 epitopes can identify human renal progenitors. Kidney Int, 2010,78(6):620-621.
doi: 10.1038/ki.2010.243
|
| [59] |
Itai S, Fujii Y, Nakamura T , et al. Establishment of CMab-43, a sensitive and specific anti-CD133 monoclonal antibody, for immunohistochemistry. Monoclon Antib Immunodiagn Immunother, 2017,36(5):231-235.
doi: 10.1089/mab.2017.0031
|
| [60] |
Fargeas C A, Joester A, Missol-Kolka E , et al. Identification of novel Prominin-1/CD133 splice variants with alternative C-termini and their expression in epididymis and testis. J Cell Sci, 2004,117(Pt 18):4301-4311.
doi: 10.1242/jcs.01315
|
| [61] |
Shmelkov S V, Jun L, St Clair R , et al. Alternative promoters regulate transcription of the gene that encodes stem cell surface protein AC133. Blood, 2004,103(6):2055-2061.
doi: 10.1182/blood-2003-06-1881
|
| [62] |
Weng C C, Kuo K K, Su H T , et al. Pancreatic tumor progression associated with CD133 overexpression: involvement of increased TERT expression and epidermal growth factor receptor-dependent Akt activation. Pancreas, 2016,45(3):443-457.
doi: 10.1097/MPA.0000000000000460
|
| [63] |
Mak A B, Nixon A M, Moffat J . The mixed lineage leukemia (MLL) fusion-associated gene AF4 promotes CD133 transcription. Cancer Res, 2012,72(8):1929-1934.
doi: 10.1158/0008-5472.CAN-11-3589
|
| [64] |
Xin B, He X, Wang J , et al. Nerve growth factor regulates CD133 function to promote tumor cell migration and invasion via activating ERK1/2 signaling in pancreatic cancer. Pancreatology, 2016,16(6):1005-1014.
doi: 10.1016/j.pan.2016.09.005
|
| [65] |
Dellett M, Sasai N, Nishide K , et al. Genetic background and light-dependent progression of photoreceptor cell degeneration in Prominin-1 knockout mice. Invest Ophthalmol Vis Sci, 2014,56(1):164-176.
|
| [66] |
Latorre E, Carelli S, Raimondi I , et al. The ribonucleic complex HuR-MALAT1 represses CD133 expression and suppresses epithelial-mesenchymal transition in breast cancer. Cancer Res, 2016,76(9):2626-2636.
doi: 10.1158/0008-5472.CAN-15-2018
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
| |
Shared |
|
|
|
|
| |
Discussed |
|
|
|
|
